As part of a service expansion program, Novotech has acquired US CRO NCGS, a full service CRO managing clinical trials since 1984 and can now offer CRO services to biotech clients in the US to support early and late phase global studies.   
 
This is an important move forward as it enables us to provide US-based expertise and deep infrastructure for US clients wanting trials in APAC and the US, and for APAC clients wanting US clinical programs.  
 
This increased focus in the US first began in 2017 with on-the-ground presence in San Francisco in 2017, to Boston in 2018.  Novotech has significantly increased its presence in North America to accommodate the rising demand of US biotechnology companies for CRO services in the Asia-Pacific region.

Novotech discusses biotech clinical development plans in Asia and Australia at OCT conference in Boston

Novotech sees increased interest from US biotechs in Asia-pacific at OCT Southern California in La Jolla

Meet the team at any of those upcoming events in North America

List of events (only North America locations)